Compare YELP & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YELP | NEO |
|---|---|---|
| Founded | 2004 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2011 | 2008 |
| Metric | YELP | NEO |
|---|---|---|
| Price | $26.02 | $16.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $29.17 | $13.38 |
| AVG Volume (30 Days) | 947.3K | ★ 3.0M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.15 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $1,464,955,000.00 | N/A |
| Revenue This Year | $2.19 | $10.63 |
| Revenue Next Year | $2.34 | $9.73 |
| P/E Ratio | $83.47 | ★ N/A |
| Revenue Growth | ★ 3.75 | N/A |
| 52 Week Low | $19.60 | $5.65 |
| 52 Week High | $34.49 | $16.45 |
| Indicator | YELP | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 59.79 |
| Support Level | $23.87 | $13.43 |
| Resistance Level | $27.67 | N/A |
| Average True Range (ATR) | 1.16 | 0.81 |
| MACD | -0.17 | 0.04 |
| Stochastic Oscillator | 26.07 | 73.82 |
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.